Promising Therapeutic Targets in Neuroblastoma : Progress in Pediatric CancerMATTHAY, Katherine K; GEORGE, Rani E; YU, Alice L et al.Clinical cancer research (Print). 2012, Vol 18, Num 10, pp 2740-2753, issn 1078-0432, 14 p.Article

Adverse impact of regional lymph node involvement in osteosarcomaTHAMPI, Sheila; MATTHAY, Katherine K; GOLDSBY, Robert et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3471-3476, issn 0959-8049, 6 p.Article

Ethnic and Racial Differences in Patients With Ewing SarcomaWORCH, Jennifer; MATTHAY, Katherine K; NEUHAUS, John et al.Cancer. 2010, Vol 116, Num 4, pp 983-988, issn 0008-543X, 6 p.Article

Racial Differences in the Incidence of Mesenchymal Tumors Associated with EWSR1 TranslocationWORCH, Jennifer; CYRUS, Jobin; GOLDSBY, Robert et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 3, pp 449-453, issn 1055-9965, 5 p.Article

Retinoid therapy of high-risk neuroblastomaREYNOLDS, C. Patrick; MATTHAY, Katherine K; VILLABLANCA, Judith G et al.Cancer letters. 2003, Vol 197, Num 1-2, pp 185-192, issn 0304-3835, 8 p.Article

Response, Survival, and Toxicity After Iodine-131-Metaiodobenzylguanidine Therapy for Neuroblastoma in Preadolescents, Adolescents, and AdultsPOLISHCHUK, Alexei L; DUBOIS, Steven G; HAAS-KOGAN, Daphne et al.Cancer. 2011, Vol 117, Num 18, pp 4286-4293, issn 0008-543X, 8 p.Article

Secondary myelodysplastic syndrome and leukemia following ¹³¹I-metaiodobenzylguanidine Therapy for relapsed neuroblastomaWEISS, Brian; VORA, Amish; HUBERTY, John et al.Journal of pediatric hematology/oncology. 2003, Vol 25, Num 7, pp 543-547, issn 1077-4114, 5 p.Article

A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastomaFERNANDEZ, M. Carmen; KRAILO, Mark D; GERBING, Robert R et al.Cancer. 2000, Vol 88, Num 12, pp 2838-2844, issn 0008-543XArticle

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG projectANGELINI, Paola; LONDON, Wendy B; IRWIN, Meredith S et al.European journal of cancer (1990). 2012, Vol 48, Num 8, pp 1185-1191, issn 0959-8049, 7 p.Article

Neuroblastoma imaging using a combined CT scanner-scintillation camera and ¹³¹I-MIBGTANG, H. Roger; DA SILVA, Angela J; MATTHAY, Katherine K et al.The Journal of nuclear medicine (1978). 2001, Vol 42, Num 2, pp 237-247, issn 0161-5505Article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-A report from the Children's cancer group studyRUDNICK, Emily; KHAKOO, Yasmin; ANTUNES, Nuno L et al.Medical and pediatric oncology. 2001, Vol 36, Num 6, pp 612-622, issn 0098-1532Article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-A report from the children's cancer groupCOOPER, Robert; KHAKOO, Yasmin; MATTHAY, Katherine K et al.Medical and pediatric oncology. 2001, Vol 36, Num 6, pp 623-629, issn 0098-1532Article

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome : Relationship to MRI findings and anti-neuronal antibodiesHAYWARD, Kristen; JEREMY, Rita J; JENKINS, Sheila et al.The Journal of pediatrics. 2001, Vol 139, Num 4, pp 552-559, issn 0022-3476Article

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group ProjectMOROZ, Veronica; MACHIN, David; MATTHAY, Katherine K et al.European journal of cancer (1990). 2011, Vol 47, Num 4, pp 561-571, issn 0959-8049, 11 p.Article

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid : A Children's Oncology Group StudyMATTHAY, Katherine K; REYNOLDS, C. Patrick; SEEGER, Robert C et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1007-1013, issn 0732-183X, 7 p.Article

Phase I Study of ch 14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue : A Report From the Children's Oncology GroupGILMAN, Andrew L; FEVZI OZKAYNAK, M; SONDEL, Paul M et al.Journal of clinical oncology. 2009, Vol 27, Num 1, pp 85-91, issn 0732-183X, 7 p.Article

Central nervous system metastases in neuroblastoma: Radiologic, clinical, and biologic features in 23 patientsMATTHAY, Katherine K; BRISSE, Hervé; COUANET, Dominique et al.Cancer. 2003, Vol 98, Num 1, pp 155-165, issn 0008-543X, 11 p.Article

Impact of radiotherapy for high-risk neuroblastoma: A children's cancer group studyHAAS-KOGAN, Daphne A; SWIFT, Patrick S; SELCH, Michael et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 28-39, issn 0360-3016, 12 p.Article

Revision of the International Neuroblastoma Pathology classification: Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodularPEUCHMAUR, Michel; D'AMORE, Emanuele S. G; SHIMADA, Hiroyuki et al.Cancer. 2003, Vol 98, Num 10, pp 2274-2281, issn 0008-543X, 8 p.Article

Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomasBERTUCIO, Clare S; WARA, William M; MATTHAY, Katherine K et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 3, pp 763-769, issn 0360-3016Conference Paper

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyMINTURN, Jane E; EVANS, Audrey E; BRODEUR, Garrett M et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 1057-1065, issn 0344-5704, 9 p.Article

Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group StudyPARK, Julie R; SCOTT, Jeffrey R; STEWART, Clinton F et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4351-4357, issn 0732-183X, 7 p.Article

Outcome after Reduced Chemotherapy for Intermediate-Risk NeuroblastomaBAKER, David L; SCHMIDT, Mary L; SHAMBERGER, Robert C et al.The New England journal of medicine. 2010, Vol 363, Num 14, pp 1313-1323, issn 0028-4793, 11 p.Article

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [¹⁸F] Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed NeuroblastomaTAGGART, Denah R; HAN, Myo M; HAWKINS, Randall et al.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5343-5349, issn 0732-183X, 7 p.Article

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network studyTHOMPSON, Patrick A; ROSNER, Gary L; MATTHAY, Katherine K et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 243-251, issn 0344-5704, 9 p.Article